MELK and breast carcinoma: More importantly, the comparison of MTT assays in parental adherent SCLC cells and LS-derived SCLC cells revealed that OTS167 more effectively suppressed the growth of the latter cells as MELK inhibition by siRNA or OTS167 on breast cancer cells reported previously [9].